Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Immunology Letters
|
April 6, 2010
Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells
Cornelia M Spies, Timo Gaber, Martin Hahne, et al.
Arthritis Research & Therapy
|
August 4, 2023
Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis
Tazio Maleitzke, Edgar Wiebe, Dörte Huscher, et al.
The Journal of Rheumatology
|
September 9, 2006
Membrane glucocorticoid receptor expression on peripheral blood mononuclear cells in patients with ankylosing spondylitis
Anita B Tryc, Cornelia M Spies, Udo Schneider, et al.
Arthritis and Rheumatism
|
July 1, 2009
Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo
Frank Buttgereit, Hong Zhou, Robert Kalak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 14, 2004
Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis
Burkhard Bartholome, Cornelia M Spies, Timo Gaber, et al.
Bone
|
April 11, 2009
Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice
Robert Kalak, Hong Zhou, Janine Street, et al.
Clinical and Experimental Rheumatology
|
December 24, 2014
Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study
Cornelia M Spies, Paula Hoff, Jeannine Mazuch, et al.
Arthritis and Rheumatism
|
September 8, 2011
Origin and functional activity of the membrane-bound glucocorticoid receptor
Cindy Strehl, Timo Gaber, Mark Löwenberg, et al.
Annals of the Rheumatic Diseases
|
March 3, 2016
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Cindy Strehl, Johannes W J Bijlsma, Maarten de Wit, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Immunology Letters
|
April 6, 2010
Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells
Cornelia M Spies, Timo Gaber, Martin Hahne, et al.
Arthritis Research & Therapy
|
August 4, 2023
Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis
Tazio Maleitzke, Edgar Wiebe, Dörte Huscher, et al.
The Journal of Rheumatology
|
September 9, 2006
Membrane glucocorticoid receptor expression on peripheral blood mononuclear cells in patients with ankylosing spondylitis
Anita B Tryc, Cornelia M Spies, Udo Schneider, et al.
Arthritis and Rheumatism
|
July 1, 2009
Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo
Frank Buttgereit, Hong Zhou, Robert Kalak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 14, 2004
Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis
Burkhard Bartholome, Cornelia M Spies, Timo Gaber, et al.
Bone
|
April 11, 2009
Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice
Robert Kalak, Hong Zhou, Janine Street, et al.
Clinical and Experimental Rheumatology
|
December 24, 2014
Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study
Cornelia M Spies, Paula Hoff, Jeannine Mazuch, et al.
Arthritis and Rheumatism
|
September 8, 2011
Origin and functional activity of the membrane-bound glucocorticoid receptor
Cindy Strehl, Timo Gaber, Mark Löwenberg, et al.
Annals of the Rheumatic Diseases
|
March 3, 2016
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Cindy Strehl, Johannes W J Bijlsma, Maarten de Wit, et al.
Page
of 2